The study of antiatherogenic properties of a new combined agent based on the carrot root thick extract and quercetin on the model of experimental atherosclerosis in rabbits
News of Pharmacy · 31.03.2026 · 111 (1) · 125-131
DOI: 10.24959/nphj.26.198 ↗Kurz gefasst
Fachartikel in der Zeitschrift News of Pharmacy, online erschienen am 31.03.2026. Verfasst von T. R. Kononenko und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aim
To study antiatherogenic properties of a new combined agent based on the carrot root thick extract and quercetin on the model of experimental atherosclerosis in rabbits. Materials and methods. Experimental atherosclerosis was reproduced by oral administration of an oil solution of cholesterol in the dose of 0.3 g/kg to rabbits for 3 months. A combined agent based on the carrot root thick extract and quercetin in the dose of 200 mg/kg and reference drugs simvastatin tablets in the dose of 5 mg/kg, nicotinic acid tablets in the dose of 180 mg/kg, and “Ravisol” tincture (Visci albi сormi et folia; Equiseti arvensis herba; Sophora japonica fructus; Hippocastani semina; Crataegi fructus; Trifolii flores; Vincae minoris hеrbа) in the dose of 360 mg/kg were administered in a therapeutic and prophylactic mode once daily during the reproduction of the pathology for 3 months. The antiatherogenic effect of the agents was assessed by the content of total cholesterol, triglycerides, LDL-C, HDL-C in the blood serum and the atherogenicity coefficient.
Results
It was found that the combined agent based on the carrot root thick extract and quercetin when administered for therapeutic and prophylactic purposes exhibited pronounced antiatherogenic properties, which were indicated by a statistically significant decrease in total cholesterol by 38.3 %, triglycerides by 37.4 %, and LDL-C by 45.7 %, respectively, and, at the same time, an increase in the HDL-C content by 27.6 % and a decrease in the atherogenicity coefficient by 2.9 times compared to the control pathology group. The mechanism of action includes hypolipidemic, hypoglyceridemic, and hypocholesterolemic effects, in which the combined agent does not differ from simvastatin tablets and surpasses nicotinic acid tablets and combined herbal preparation – “Ravisol” tincture.
Conclusions
When rabbits were administered cholesterol for 3 months, significant changes in the lipid spectrum of the blood serum were observed, indicating the development of atherogenic disorders. The combined agent based on the carrot root thick extract and quercetin, with therapeutic and preventive administration against the background of a cholesterol diet shows pronounced antiatherogenic properties at the level of the hypolipidemic agent – simvastatin tablets. The results obtained substantiate the feasibility of further pharmacological studies of a combined agent based on the carrot root thick extract and quercetin as a promising antiatherogenic drug.
Zitieren
APA
Kononenko, T. R., & Chikitkina, V. V. (2026). The study of antiatherogenic properties of a new combined agent based on the carrot root thick extract and quercetin on the model of experimental atherosclerosis in rabbits. News of Pharmacy, 111(1), 125-131. https://doi.org/10.24959/nphj.26.198
Vancouver
Kononenko TR, Chikitkina VV. The study of antiatherogenic properties of a new combined agent based on the carrot root thick extract and quercetin on the model of experimental atherosclerosis in rabbits. News of Pharmacy. 2026;111(1):125-131. doi:10.24959/nphj.26.198
BibTeX
@article{Kononenko2026,
author = {Kononenko, T. R. and Chikitkina, V. V.},
title = {The study of antiatherogenic properties of a new combined agent based on the carrot root thick extract and quercetin on the model of experimental atherosclerosis in rabbits},
journal = {News of Pharmacy},
year = {2026},
volume = {111},
number = {1},
pages = {125--131},
doi = {10.24959/nphj.26.198}
}
EUVIMED